Women and heart failure

Area of Science:

• Cardiology
• Women's Health
• Clinical Research

Background:

• Congestive heart failure (CHF) affects nearly half of US women, yet they are underrepresented in clinical studies.
• Existing research often generalizes findings from male populations to women, overlooking key differences.
• Women with CHF frequently present with distinct characteristics such as older age, hypertension, and higher ejection fractions.

Purpose of the Study:

• To highlight the underrepresentation of women in congestive heart failure (CHF) research.
• To emphasize the need for tailored clinical trials addressing women's specific cardiovascular profiles and treatment responses.
• To advocate for future research that includes diverse female populations, particularly older women with diastolic dysfunction.

Main Methods:

• Review of existing literature on congestive heart failure (CHF) in women versus men.
• Analysis of demographic and clinical characteristic differences between male and female CHF patients.
• Identification of gaps in clinical trial participation and treatment strategies for women with CHF.

Main Results:

• Women with CHF often exhibit unique physiological characteristics and comorbidities compared to men.
• Conflicting survival data exists, necessitating further investigation in female populations.
• Diastolic dysfunction is more prevalent in women, impacting functional status and exercise intolerance.
• Current treatment protocols for diastolic dysfunction are less defined, with limited clinical trials involving women.

Conclusions:

• There is a critical need to increase female participation in congestive heart failure (CHF) clinical trials.
• Future research should focus on understanding sex-based differences in cardiovascular physiology and pharmacologic responses.
• Clinical trial designs must accommodate older women and those with diastolic dysfunction to improve CHF management.